Kivanc Yuksel

Kivanc Yuksel

Auto-generated profile, based on publicly available information

Kivanc Yuksel

Ege University School of Medicine ARGEFAR, İzmir, Turkey

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in United European Gastroenterology Journal
Verified
Journal Article
Open access
PDF file
SBSerhat Bor
Serhat Bor
MDMesut Demir
Mesut Demir
OOOktay Ozdemir
Oktay Ozdemir
KYKivanc Yuksel
Kivanc Yuksel
Background: This meta‐analysis aimed to assess the cardiac safety profile of domperidone treatment for the risk of cardiovascular (CV) event and QT prolongation.Methods: Data from nine studies involving 101,155 patients were used for the analysis of CV event risk, while data from eight studies involving 390 patients were used for the analysis of QT prolongation risk.Results: Meta‐analysis findings suggested a significant increase in CV risk under domperidone as compared to no treatment for domperidone doses of >30 mg/day (OR: 3.14, 95% CI, 1.191 to 8.304, p = 0.021), no significant increase in QT prolongation event rates with domperidone (3.54%, 95% CI, 1.73% to 7.10%) and a significantly lower CV risk for domperidone than for metoclopramide (OR: 0.63, 95% CI, 0.58 to 0.70, p < 0.001).Conclusions: The present meta‐analysis indicates that domperidone treatment may not be associated with an overall CV event risk increase at doses ≤30 mg/day and does not result in QT prolongation.

27 October 2015 in Cardiology Journal
Verified
Journal Article
Open access
UTUgur Onsel Turk
Ugur Onsel Turk
ETEsref Tuncer
Esref Tuncer
EAEmin Alioglu
Emin Alioglu
KYKivanc Yuksel
Kivanc Yuksel
NPNihat Pekel
Nihat Pekel
ITIstemihan Tengiz
Istemihan Tengiz
Warfarin is highly efficacious in reducing stroke risk in patients with atrial fibrillation (AF). However, its safety and efficacy in stroke prevention is markedly influenced by its time in therapeutic range (TTR). The quality of anticoagulant therapy varies considerably among countries. Representative data concerning the quality of anticoagulant therapy and its effects on clinical outcomes in Turkey are lacking. Warfarin in Therapeutic Range (WATER) registry is a prospective, observational study which followed 572 AF patients (mean age 67.3 ± 12 years; females 60%; 71% non-valvular AF) treated with warfarin. At a median of 22-month follow-up, the mean TTR value was 42.3 ± 18% (median: 40%) for the whole population and lower in non-valvular AF su group than valvular AF subgroup (40.3 ± 18 vs. 46.9 ± 19, respectively, p < 0.001). Death, cardiac hospital-ization and minor bleeding rates were higher in the group with TTR value < 40% than the group with > 40% (3.4% vs. 5.9%; 28.6% vs. 35.4%; 36.5% vs. 41.7%, respectively, all of them p < 0.001). A correlation analysis showed a negative correlation between age and TTR value (r = -0.178, p < 0.001). Mean CHA2DS2VASc score was 3.63 ± 1.5 and mean HASBLED score was 2.38 ± 1.01 in the non-valvular AF group. A negative correlation was observed between TTR levels and CHA2DS2VASc score. WATER provides insight into the anticoagulation control status of AF patients in Turkey. The quality of anticoagulation was poor. Strategies should be undertaken by clinicians and patients to improve TTR. New oral anticoagulant agents may be perfect alternatives for non-valvular AF patients.

1 January 2005 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
MYMurvet Yuksel
Murvet Yuksel
HKHamza Karabiber
Hamza Karabiber
KYK. Zafer Yuksel
K. Zafer Yuksel
GPGonul Parmaksiz
Gonul Parmaksiz
Yuksel M, et al. Korean J Radiol. 2005 Oct-Dec;6(4):278-281. http://dx.doi.org/10.3348/kjr.2005.6.4.278

12 March 2019 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
KYKıvanç Yüksel
Kıvanç Yüksel
ITIşık Tuğlular
Işık Tuğlular

12 March 2019 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
MEMuhittin Ertilav
Muhittin Ertilav
WLW. Nathan Levin
W. Nathan Levin
ACAygul Celtik
Aygul Celtik
FKFatih Kircelli
Fatih Kircelli
Stefano StuardStefano Stuard
Stefano Stuard
GAGulay Asci
Gulay Asci